2020
DOI: 10.30978/cees-2020-1-36
|View full text |Cite
|
Sign up to set email alerts
|

A study of the prognostic value of leptin to assess the risk of progression of diabetic retinopathy in patients with type 2 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
1
0
0
Order By: Relevance
“…There are also hypoglycemic drugs that can reduce leptin levels in T2DM patients, including metformin, pioglitazone, sitagliptin, liraglutide and enparizine [79][80][81]. Many clinical studies had confirmed the relationship between leptin and hypertension [82,83], DR [84][85][86], DN [87,88], DM [89], DPN [90] and CHD [91,92]. These studies are consistent with, or similar to, our study.…”
Section: Discussionsupporting
confidence: 90%
“…There are also hypoglycemic drugs that can reduce leptin levels in T2DM patients, including metformin, pioglitazone, sitagliptin, liraglutide and enparizine [79][80][81]. Many clinical studies had confirmed the relationship between leptin and hypertension [82,83], DR [84][85][86], DN [87,88], DM [89], DPN [90] and CHD [91,92]. These studies are consistent with, or similar to, our study.…”
Section: Discussionsupporting
confidence: 90%